Dr. Kapil N. Bhalla, MD

Dr. Bhalla practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Bhalla's NPI, 1609806819, was assigned on July 4, 2006. Dr. Bhalla graduated from Maulana Azad Medical College in 1976. Dr. Bhalla's Texas license number on file is R5245.

Dr. Bhalla's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Bhalla's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhalla practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bhalla's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bhalla is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Bhalla's licenses on file in 6 states: Texas, New York, Florida, Georgia, South Carolina and New Jersey.

CMS data shows 93 Medicare services from Dr. Bhalla across 1 procedure code in 2024, for 22 Medicare patients. Medicare paid $8,667 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 22 Medicare patients who saw Dr. Bhalla in 2024. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 4.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhalla's median patient age at 67, with 40% women.

In 2024, Dr. Bhalla wrote 16 Medicare Part D claims. 88% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $112 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bhalla for performance year 2024, reported as part of a group.

Dmand AI links 334 papers to Dr. Bhalla, published from 2002 to 2025. 2020 was the busiest year, with 18. The most frequent topics are Apoptosis, Leukemia, Myeloid, Acute and Antineoplastic Agents. Dr. Bhalla has published most often in Blood. Dr. Bhalla's most frequent co-authors are Courtney Denton Dinardo, MD, Tapan M. Kadia, MD and Naval Gustad Daver, MBBS.

Dmand AI links Dr. Bhalla to 1 clinical trial. Conditions studied include Precursor T-Cell Lymphoblastic Leukemia-Lymphoma and Precursor Cell Lymphoblastic Leukemia-Lymphoma.

CMS Open Payments shows 6 general payments to Dr. Bhalla from 4 drug and device companies from 2016 to 2019. Consulting fees make up the largest share, 82% of the total. R-Pharm US LLC paid the most, $1,306.

Dr. Bhalla graduated from Maulana Azad Medical College in 1976.

Dr. Bhalla is in network with 3 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 3. Check the plan with the practice before a visit.